Define Ventures Appoints Bruce Broussard as Venture Partner
Define Ventures, a major venture capital firm focusing on early-stage health tech companies, has appointed Bruce Broussard as venture partner. Broussard, former CEO and president of Humana, brings extensive experience in scaling companies and fostering innovation across various healthcare sectors. His role will involve guiding founders, shaping investment strategies, and strengthening partnerships with large healthcare organizations.
Broussard's decision to join Define Ventures is rooted in his belief in the firm's unique position to transform healthcare. His appointment follows that of Frank Williams, co-founder and former CEO of Evolent, who joined as venture partner earlier this year. Define Ventures, with $800 million in assets under management, partners with companies at seed, series A, and series B stages, including notable firms like Hims & Hers and Unite Us.
Define Ventures, una importante società di venture capital che si concentra sulle aziende emergenti nel settore della tecnologia sanitaria, ha nominato Bruce Broussard come partner di venture. Broussard, ex CEO e presidente di Humana, porta con sé un'esperienza vasta nella scalabilità delle aziende e nella promozione dell'innovazione nei vari settori della salute. Il suo ruolo prevede di guidare i fondatori, definire strategie di investimento e rafforzare le partnership con grandi organizzazioni sanitarie.
La decisione di Broussard di unirsi a Define Ventures è radicata nella sua convinzione nella posizione unica della società per trasformare il settore sanitario. La sua nomina segue quella di Frank Williams, co-fondatore ed ex CEO di Evolent, che si è unito come partner di venture all'inizio di quest'anno. Define Ventures, con 800 milioni di dollari in gestione, collabora con aziende nelle fasi seed, serie A e serie B, compresi nomi noti come Hims & Hers e Unite Us.
Define Ventures, una importante firma de capital de riesgo que se centra en empresas emergentes de tecnología en salud, ha designado a Bruce Broussard como socio de venture. Broussard, ex CEO y presidente de Humana, aporta una amplia experiencia en el escalado de empresas y en la promoción de la innovación en diversos sectores de la salud. Su papel consistirá en guiar a los fundadores, formular estrategias de inversión y fortalecer las asociaciones con grandes organizaciones de salud.
La decisión de Broussard de unirse a Define Ventures se basa en su creencia en la posición única de la firma para transformar el sector salud. Su nombramiento sigue al de Frank Williams, cofundador y ex CEO de Evolent, quien se unió como socio de venture a principios de este año. Define Ventures, con 800 millones de dólares en activos bajo gestión, colabora con empresas en las etapas seed, serie A y serie B, incluyendo firmas notables como Hims & Hers y Unite Us.
Define Ventures는 초기 단계의 헬스케어 기술 회사에 주목하는 주요 벤처 캐피탈 회사로, 브루스 브루사드를 벤처 파트너로 임명했습니다. 브루사드는 휴마나의 전 CEO이자 사장으로, 다양한 헬스케어 분야에서 기업의 성장과 혁신을 촉진한 경험이 풍부합니다. 그의 역할은 창립자를 안내하고 투자 전략을 형성하며 대규모 헬스케어 조직과의 파트너십을 강화하는 것입니다.
브루사드가 Define Ventures에 합류하기로 한 결정은 회사가 헬스케어를 변혁할 수 있는 독특한 위치에 있다는 그의 믿음에 뿌리를 두고 있습니다. 그의 임명은 올해 초 벤처 파트너로 합류한 에볼렌트의 공동 창립자이자 전 CEO인 프랭크 윌리엄스의 뒤를 잇습니다. Define Ventures는 8억 달러의 자산을 관리하며, Hims & Hers 및 Unite Us와 같은 주목할 만한 회사들과 함께 씨드, 시리즈 A, 시리즈 B 단계에서 협력합니다.
Define Ventures, une importante société de capital-risque se concentrant sur les entreprises de technologie de la santé en phase de démarrage, a nommé Bruce Broussard en tant que partenaire de capital-risque. Broussard, ancien PDG et président de Humana, apporte une vaste expérience dans la mise à l'échelle des entreprises et la promotion de l'innovation dans divers secteurs de la santé. Son rôle consistera à guider les fondateurs, façonner les stratégies d'investissement et renforcer les partenariats avec de grandes organisations de santé.
La décision de Broussard de rejoindre Define Ventures est ancrée dans sa conviction en la position unique de la société pour transformer le secteur de la santé. Sa nomination fait suite à celle de Frank Williams, co-fondateur et ancien PDG d'Evolent, qui a rejoint en tant que partenaire de capital-risque plus tôt cette année. Define Ventures, avec 800 millions de dollars d'actifs sous gestion, s'associe à des entreprises aux étapes seed, série A et série B, y compris des entreprises notables comme Hims & Hers et Unite Us.
Define Ventures, eine führende Venture-Capital-Firma, die sich auf frühphasige Unternehmen im Gesundheitsbereich konzentriert, hat Bruce Broussard zum Venture-Partner ernannt. Broussard, ehemaliger CEO und Präsident von Humana, bringt umfassende Erfahrung im Skalieren von Unternehmen und der Förderung von Innovationen in verschiedenen Gesundheitssektoren mit. Seine Rolle wird darin bestehen, Gründer zu unterstützen, Investitionsstrategien zu gestalten und Partnerschaften mit großen Gesundheitsorganisationen zu stärken.
Broussards Entscheidung, zu Define Ventures zu stoßen, beruht auf seinem Glauben an die einzigartige Position der Firma, das Gesundheitswesen zu transformieren. Seine Ernennung folgt auf die von Frank Williams, Mitbegründer und ehemaliger CEO von Evolent, der zu Beginn dieses Jahres als Venture-Partner dazugestoßen ist. Define Ventures verwaltet 800 Millionen Dollar in Vermögenswerten und arbeitet mit Unternehmen in den Phasen Seed, Serie A und Serie B zusammen, darunter namhafte Firmen wie Hims & Hers und Unite Us.
- Appointment of Bruce Broussard, former Humana CEO, as venture partner
- Broussard's extensive experience in scaling healthcare companies
- $800 million in assets under management
- Partnerships with notable companies like Hims & Hers (NYSE: HIMS)
- None.
The former Fortune 50 CEO joins Define to further drive transformational change in healthcare at the earliest stages of innovation
Bruce is a seasoned healthcare executive and multi-time CEO, having held executive leadership positions across multiple corners of the ecosystem. Prior to joining Define, Bruce was president and CEO of Humana for over a dozen years. Under his leadership, Bruce led a strategic shift towards expanding the company into an integrated model with a growing care delivery focus. Bruce also held several roles at McKesson Specialty Health including CEO, CFO, President, and Chairman of the Board. He currently serves on the Humana Foundation Board, is Chair of the Board of Directors of the Trust for the National Mall, and is a board member for HP Inc. and One Call.
"Bruce's extensive background and proven track record in leading healthcare organizations of all sizes makes him uniquely qualified to guide the next generation of health tech innovators," said Lynne Chou O'Keefe, founder and managing partner at Define Ventures. "Having had the privilege to closely partner with Bruce for the past decade, I am confident his decision to join our team will sharpen our investing theses, accelerate our partner companies' growth, strengthen our relationships with large healthcare organizations, and ultimately create a lasting impact on the broader health tech community."
Bruce is joining a team that pulls the full weight of its network and expertise to play offense and drive results, including securing early customers, shaping commercial strategies, and building high-performing teams. As venture partner, Bruce will leverage his experience driving transformative change within complex healthcare organizations to help Define founders to navigate industry challenges and scale their innovations effectively. His perspective will also strengthen Define's close partnerships with its coalition of large health systems, health plans, employers, and life sciences companies, half of which are customers of Define partner companies.
"What excites me the most about this role is the opportunity to work with brilliant, innovative entrepreneurs at the earliest stages of their journey," Broussard said. "Being able to see groundbreaking approaches from the start, and having the chance to shape products and help scale and bring them to market is truly invigorating. Ultimately, I chose to work with Define because I believe this firm is uniquely positioned and capable of driving real transformation in healthcare. The strong, trustworthy relationship we've built over the years has shown me that Define's vision aligns perfectly with my own. Together, I believe we can make significant strides in creating a healthcare system that's more efficient, more accessible, and more focused on keeping people healthy."
Bruce's decision to join Define Ventures stems from his belief that the firm is uniquely positioned and capable of transforming healthcare. He has built a strong and trustworthy relationship with Define over the past several years, including first-hand experience in incubating and spinning out Cohere Health from Humana. This collaborative history underscores the alignment between Bruce's vision for healthcare innovation and Define's strategic approach.
Define Ventures has
To learn more about Define Ventures, visit www.definevc.com.
About Define Ventures
Define Ventures is one of the largest funds focused on early-stage health tech companies. With
View original content:https://www.prnewswire.com/news-releases/define-ventures-appoints-bruce-broussard-as-venture-partner-302282546.html
SOURCE Define Ventures
FAQ
Who is Bruce Broussard and what is his new role at Define Ventures?
How much assets under management does Define Ventures have?
What types of companies does Define Ventures invest in?
Who else recently joined Define Ventures as a venture partner?
